Department of Pharmaceutical Engineering, School of Chemical Engineering, Xiangtan University, Xiangtan, 411105, People's Republic of China.
Department of Pharmaceutical Engineering, School of Chemical Engineering, Xiangtan University, Xiangtan, 411105, People's Republic of China.
J Ethnopharmacol. 2019 Oct 28;243:112125. doi: 10.1016/j.jep.2019.112125. Epub 2019 Jul 29.
The combination of Chuanxiong Rhizoma (Ligusticum chuanxiong Hort., umbelliferae) with Xiangfu Rhizoma (the rhizoma of Cyperus rotundus L., Cyperaceae), is deemed as CR-XR herb-pair (Yaodui) in China. Their compatible mechanism needs a further research using modern analytical techniques and bioinformatic tool.
Head Space- Solid Phase Micro Extraction coupled with Gas Chromatography/Mass Spectrometer detection (HS-SPME-GC/MS) and Liquid Chromatography coupled to quadrupole Time of Flight - Mass Spectrometry (LC-qTOF-MS) were applied in an accurate identification of the absorbed phytochemicals in mice serum; Their potential targets were available after compound-protein interaction (CPI) prediction and molecular docking verification; Then the corresponding disease types, as well as the relevant Traditional Chinese Medicine (Zhongyi) syndromes (Zheng), were matched from databases and references.
Resolution from hyphenated chromatographic datasets, thirty-eight phytochemicals were detected in serum samples from mice. Seventy potential target proteins were thereby found through a bioinformatic calculation, which mainly focused on circulatory, endocrine and nervous diseases in Western medicine, also related with Qizhi and Xueyu Zheng from the perspective of Zhongyi. Part of the relationships among compound-Target-Disease have been confirmed by literatures. These virtual data were sketched out as 'The active Compound - potential Target' network, 'Target - Disease' network and 'Target - Zhongyi Disease' network, in which the network topology was used to analyze them.
Our work successfully explained the compatible mechanism of CR-XR Yaodui, which exert 'multi-components, multi targets' in treating Qizhi and Xueyu Zheng.
川芎-香附药对的整合分析
川芎(伞形科藁本属植物川芎 Ligusticum chuanxiong Hort.)与香附(莎草科莎草属植物香附子 Cyperus rotundus L.)合用在中国被视为药对(药对)。其配伍机制需要进一步研究,采用现代分析技术和生物信息学工具。
采用顶空固相微萃取结合气相色谱/质谱联用(HS-SPME-GC/MS)和液相色谱-四极杆飞行时间质谱联用(LC-qTOF-MS)对小鼠血清中吸收的植物化学成分进行准确鉴定;通过化合物-蛋白质相互作用(CPI)预测和分子对接验证,获得其潜在靶点;然后从数据库和参考文献中匹配相应的疾病类型以及相关的中医(中医)证候(证)。
从联用时的色谱数据集中解析,在小鼠血清样品中检测到 38 种植物化学物质。通过生物信息学计算,发现了 70 个潜在的靶蛋白,主要集中在西医的循环、内分泌和神经系统疾病,从中医的气、血证角度也与气、血证有关。部分化合物-靶标-疾病的关系已被文献证实。这些虚拟数据被描绘为“活性化合物-潜在靶标”网络、“靶标-疾病”网络和“靶标-中医疾病”网络,其中网络拓扑结构用于对其进行分析。
本研究成功阐释了 CR-XR 药对的配伍机制,即多成分、多靶点治疗气、血证。